Drug Comparison

For educational purposes only — a decision-support tool, not a substitute for clinical judgment.

Side-by-side rubric across 96 psychiatric medications. Every rating traces to a verbatim primary-source quote — click any cell to see it.

How to read this tool
Rating scale
Favorable / lower than class baseline
± Minimal / equivocal
+ Low / uncommon
++ Moderate / common
+++ High / very common
++++ Very high / class-outlier
Frequency vs severity
F = frequency, S = severity. Each gets its own pill colored on the same traffic-light scale: greenblueyelloworangered. Click any cell for incidence percentages and NNH.
Evidence tier
A Network meta-analysis / RCT / FDA label
B Cohort / registry / pooled label data
C Expert review / textbook / case series
Sourcing
Click any cell to see the verbatim source quote and citation. Missing data shows n/a.
Data depth
++ Graded — frequency + severity, primary-source traces
+ FDA label — §6 frequency only (dashed border). Click for sub-types.
  Blank — not yet checked (not “absent”)
±++++++++++ABCF = frequency · S = severity · Dashed border = FDA label only · Click cell for details
1 drug selected — Naloxone(click to collapse)
1/4 selected
Naloxone
Narcan · Kloxxado
Opioid Receptor Antagonist
FDA-approved indications
  • Emergency treatment of known or suspected opioid overdose manifested by respiratory and/or CNS depression
Off-label uses
  • Management of opioid dependence (chronic low-dose)
  • Therapeutic naloxone challenge test
MechanismCompetitive opioid antagonist; reverses opioid overdose by blocking mu-opioid receptors
Half-life~1.85-2.08 hours (intranasal); 1.24 hours (IM); 3.1 hours (neonatal)
Next:Taper Naloxone
Decision GuideWhen to pick each / when to consider an alternative
Naloxone
Consider when
  • Suspected opioid overdose in any setting (home, street, ED, hospital)
  • Respiratory depression from opioid use
  • Lay-person administration in community/harm-reduction settings (nasal spray suitable)
  • Postoperative opioid reversal (though IV formulations preferred)
Consider an alternative when
  • NOT a substitute for emergency medical services — always call EMS immediately
  • Postoperative opioid reversal where IV titrated naloxone better (can adjust dose to effect)
  • Neonatal suspected exposure where weight-based dosing and titration preferred
  • Partial agonist overdose (buprenorphine) — may require higher doses or longer surveillance
Axis
Naloxone
Opioid Antagonist
No canonical axes have data for every selected drug. Toggle "show all axes" to view partial rows.

Safety: Every rating traces to a verbatim primary-source quote. Click any cell to audit. Stubs are disabled until calibrated. This tool surfaces published evidence — it does not replace clinical judgment.